One of the implicated genetic aberrations that has shown to be prominent in chemo-resistance in AML, contributing to relapses, is the elevated expression of proteins belonging to the Bcl-2 protein family, particularly Mcl-1 (18–20). This evidence concerns the gene MCL1 and acute myeloid leukemia.